Previous Article | Next Article ![]()
Journal of Virology, April 2000, p. 3067-3073, Vol. 74, No. 7
Laboratoire
d'Immunologie1 and Laboratoire de
Biochimie Neuroendocrinienne,4 Institut de
Recherches Cliniques de Montréal, Montréal, Quebec, Canada
H2W 1R7; Département de Microbiologie-Immunologie,
Université de Montréal, Montréal, Quebec, Canada H3C
3J72; and Department of Microbiology and
Immunology, McGill University, Montréal, Quebec, Canada H3A
2B43
Received 20 September 1999/Accepted 2 November 1999
Mouse mammary tumor viruses express a superantigen essential for
their life cycle. It has been proposed that viral superantigens (vSags)
require processing by prohormone convertases (PCs) for activity. We now
observe, using a panel of mutant forms of potential PC cleavage sites
and in vitro cleavage assays, that only the CS1 (position 68 to 71) and
CS2 (position 169 to 172) sites are utilized by furin and PC5. Other
members of the convertase family that are expressed in lymphocytes are
not endowed with this activity. Furthermore, mutant forms of two
different viral superantigens, vSag7 and vSag9, which completely
abrogated in vitro processing by convertases, were efficient in
functional presentation to responsive T-cell hybridomas. This effect
was observed in both endogenous presentation and paracrine transfer of
the vSag. Processing by convertases thus appears not to be essential
for vSag function. Finally, we have identified the purified endosomal
protease cathepsin L as another protease that is able to cleave
convertase mutant vSag in vitro, yielding fragments similar to those
detected in vivo, thus suggesting that proteases other than convertases
are involved in the activation of vSags.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Alternative Proteolytic Processing of Mouse Mammary
Tumor Virus Superantigens


*
Corresponding author. Mailing address:
Laboratoire d'Immunologie, Institut de Recherches Cliniques de
Montréal (IRCM), 110 Ave. des Pins Ouest, Montréal, Quebec,
Canada H2W 1R7. Phone: (514) 987-5550. Fax: (514) 987-5711. E-mail:
sekalyr{at}ircm.qc.ca.
Present address: Centre de Recherche en Santé Humaine,
INRS-IAF, Laval, Quebec, Canada H7V 1B7.
Present address: Biométhodes, Génopôle
Industries, 91000 Evry, France.
§
Present address: Institut de Genetique et de Biologie Moleculaire
et Cellulaire, 67404 Illkirch Cedex, France.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»